{"id":"W2567464243","doi":"10.1182/blood.v116.21.4962.4962","title":"Cost-Effectiveness of Deferasirox (Exjade®) Versus No Chelation In Patients with Lower Risk Myelodysplastic Syndromes (MDS): A Canadian Perspective","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Deferasirox; Medicine; Myelodysplastic syndromes; Internal medicine; Cost effectiveness; Clinical trial; International Prognostic Scoring System; Transplantation; Quality of life (healthcare); Pediatrics; Intensive care medicine; Thalassemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001690781,0.000772465,0.001291841,0.001132903,0.000813262,0.001675547,0.00148019,0.0009666737,0.004896153],"category_scores_gemma":[0.005932079,0.0005123661,0.002531967,0.0012966,0.0006126752,0.0005679278,0.0006817871,0.001254775,0.000171095],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.04005152,"about_ca_system_score_gemma":0.03812668,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8875139,"about_ca_topic_score_gemma":0.861959,"domain_scores_codex":[0.999005,0.0003868025,0.00003283898,0.00008735282,0.0001684962,0.0003194706],"domain_scores_gemma":[0.9980058,0.001063667,0.0001939974,0.0000337833,0.0003456369,0.0003571504],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.003309936,0.000238599,0.02292489,0.001041829,0.001513213,0.0004567168,0.0001756212,0.9166918,0.0007010059,0.01984162,0.00630115,0.0268036],"study_design_scores_gemma":[0.002489888,0.00164359,0.03837232,0.001093642,0.003425523,0.0004213139,0.0006321776,0.9299787,0.0006830377,0.009792456,0.01126345,0.0002038356],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8678703,0.0323742,0.01716261,0.01828661,0.0002518031,0.001019684,0.02071188,0.0001338256,0.04218906],"genre_scores_gemma":[0.9884814,0.004782646,0.002911453,0.000382706,0.00002810039,0.00009186792,0.001705902,0.00001392869,0.001601957],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1124861,"threshold_uncertainty_score":0.2905955,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01458521959885254,"score_gpt":0.2751222337020829,"score_spread":0.2605370141032304,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}